Skip to main content
SpringerLink
Log in

Rationale for treatment of silent myocardial ischemia: Focus on nifedipine

  • Nifedipine, Cardioprotection, and Ischemic Heart Disease
  • Published:
Cardiovascular Drugs and Therapy Aims and scope Submit manuscript

Summary

The realization that the majority of ischemic episodes in ambulatory patients with coronary artery disease are not associated with angina has raised important questions regarding the medical management of such individuals. Data from studies utilizing ambulatory Holter monitoring of the ST segment suggest that ischemia is likely to be due to a combination of a modest rise in myocardial oxygen demand and a concomitant decrease in coronary perfusion. Patients with ambulatory ischemia may have a poorer survival than those without ischemia during daily activities.

This paper will address the potential impact these new findings could have on treatment. A growing body of knowledge regarding the use of nifedipine for silent ischemia will be examined. Enthusiasm to make abolition of ischemia an end point of therapy in patients with coronary artery disease will necessitate a reexamination of drugs that have been assessed largely on their ability to provide symptomatic relief.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Deanfield JE, Selwyn AP, Chierchia S, et al. Myocardial ischaemia during daily life in patients with stable angina: Its relation to symptoms and heart rate changes.Lancet 1983;2:753–758.

    Article  PubMed  CAS  Google Scholar 

  2. Cohn PF. Time for a new approach to management of patients with both symptomatic and asymptomatic episodes of myocardial ischemia.Am J Cardiol 1984;54:1358–1359.

    PubMed  CAS  Google Scholar 

  3. Schang SJ Jr, Pepine CJ. Transient asymptomatic, ST segment depression during daily activity.Am J Cordiol 1977;39:396–402.

    Google Scholar 

  4. Deanfield JE, Shea M, Ribiero P, et al. Transient ST-segment depression as a marker of myocardial ischemia during daily life.Am J Cardiol 1984;54:1195–1200.

    PubMed  CAS  Google Scholar 

  5. Deanfield JE, Kensett M, Wilson RA, et al. Silent myocardial ischaemia due to mental stress.Lancet 1984;2:1001–1004.

    Article  PubMed  CAS  Google Scholar 

  6. Deanfield JE, Shea MA, Nesto RA, et al. Direct effects of smoking on the heart, silent ischemia disturbances of coronary flow.Am J Cardiol 1986;57:1005–1009.

    Article  PubMed  CAS  Google Scholar 

  7. Quyyumi AA, Mockus LJ, Wright CA, et al. Mechanisms of nocturnal angina pectoris: Importance of increased myocardial oxygen demand in patients with severe coronary disease. Lancet 1984;1:1207–1209.

    Article  PubMed  CAS  Google Scholar 

  8. Maseri A. Role of coronary artery spasm in symptomatic and silent myocardial ischemia.J Am Coll Cardiol 1987;9: 249–262.

    Article  PubMed  CAS  Google Scholar 

  9. Brown BG, Lee AB, Bolson EL, Dodge HT. Reflex constriction of significant coronary stenosis as a mechanism contributing to ischemic left ventricular dysfunction during isometric exercise.Circulation 1984;70:18–24.

    PubMed  CAS  Google Scholar 

  10. Brown BT, Bolson EL, Dodge HT. Dynamic mechanisms in human coronary stenosis.Circulation 1984;70:917–922.

    PubMed  CAS  Google Scholar 

  11. Stone PH, Antman EM, Muller JE, Brauwald E. Calcium channel blocking agents in the treatment of cardiovascular disorders. II: Hemodynamic effects and clinical applications.Ann Intern Med 1980;93:886–904.

    PubMed  CAS  Google Scholar 

  12. Antman E, Muller J, Goldberg S, et al. Nifedipine therapy for coronary artery spasm: Experience in 27 patients.N Engl J Med 1980;302:1269–1273.

    Article  PubMed  CAS  Google Scholar 

  13. Margolis JR, Kannel WB, Feinleib M, et al. Clinical features of unrecognized myocardial infarction-silent and symptomatic. Eighteen year follow-up.Am J Cardiol 1973;32:1–7.

    PubMed  CAS  Google Scholar 

  14. Multiple Risk Factor Intervention Trial Research Group. Exercise, electrocardiogram, and coronary heart disease mortality in the Multiple Risk Factor Interventional Trial.Am J Cardiol 1985;55:16–24.

    Google Scholar 

  15. Hickman JR Jr, Ulh GS, Cook RL, et al. A natural history study of asymptomatic coronary disease (abstract).Am J Cardiol 1980;45:422.

    Google Scholar 

  16. Erikssen J, Thaulow E. Follow-up of patients with asymptomatic myocardial ischemia. In: Rutishauser W, Roskamm H, eds.Silent myocardial ischemia. Berlin: Springer-Verlag 1984:156.

    Google Scholar 

  17. Rocco MB, Nabel EG, Campbell S, et al. Prognostic importance of myocardial ischemia detected by ambulatory monitoring in patients with coronary disease (abstract).J Am Coll Cardiol 1987;62:661–664.

    Google Scholar 

  18. Tzivoni D, Gavish A, Zim D, et al. Prognostic significance of ischemic episodes in patients with previous myocardial infarction.Am J Cardiol 1988;62:661–664.

    PubMed  CAS  Google Scholar 

  19. Chierchia S. Left ventricular perfusion and function during transient asymptomatic ST-segment changes. In: Rutishauser W, Roskamm H, eds.Silent myocardial ischemia. Berlin: Springer-Verlag 1984:24.

    Google Scholar 

  20. Hirzel HO, Leutwyler R, Krayenbuehl HP. Silent myocardial ischemia: Hemodynamic changes during dynamic exercise in patients with proven coronary artery disease despite absence of angina pectoris.J Am Coll Cardiol 1985;6:275–284.

    PubMed  CAS  Google Scholar 

  21. Braunwald E, Kloner RA. The stunned myocardium: Prolonged, post-ischemic ventricular dysfunction.Circulation 1982;66:1146–1149.

    PubMed  CAS  Google Scholar 

  22. Patel B, Kloner RA, Przyklenk K, Braunwald E. Post-ischemic myocardial “stunning”: A clinically relevant phenomenon.Ann Intern Med 1988;108:626–628.

    PubMed  CAS  Google Scholar 

  23. Braunwald E, Rutherford JD. Reversible ischemic left ventricular dysfunction: Evidence for the “hibernating myocardium”.J Am Coll Cardiol 1986;8:1467–1470.

    Article  PubMed  CAS  Google Scholar 

  24. Nesto RW, Cohn LH, Collins JJ, et al. Inotropic contractile reserve: A useful predictor of increased 5-year survival and improved postoperative left ventricular function in patients with coronary artery disease and reduced ejection fraction.Am J Cardiol 1982;50:39–44.

    Article  PubMed  CAS  Google Scholar 

  25. Opie LH. Reperfusion injury and its pharmacologic modification.Circulation 1989;80:1049–1062.

    PubMed  CAS  Google Scholar 

  26. Fujibayashi Y, Yamazaki S, Chang B-L, et al. Comparative echocardiographic study of recovery of diastolic versus systolic function after brief periods of coronary occlusion: Differential effects of intravenous nifedipine administration before and during occlusion.J Am Coll Cardiol 1985;6: 1289–1298.

    PubMed  CAS  Google Scholar 

  27. Kloner RA, Przyklenk K, Patel B. Altered myocardial states.Am J Med 1989;86(Suppl 2A):14–22.

    Article  PubMed  CAS  Google Scholar 

  28. Lown B. Sudden cardiac death: The major challenge confronting contemporary cardiology.Am J Cardiol 1979:43:313–328.

    PubMed  CAS  Google Scholar 

  29. Carboni GP, Lahiri A, Cashman M, Raftery EB. Mechanisms of arrhythmias accompanying ST-segment depression on ambulatory monitoring in stable angina pectoris.Am J Cardiol 1987;60:1246–1253.

    Article  PubMed  CAS  Google Scholar 

  30. Frishman WH, Teicher M. Anti-anginal drug therapy for silent myocardial ischemia.Am Heart J 1987;114:140–147.

    Article  PubMed  CAS  Google Scholar 

  31. Oakley GDG, Fox KM, Dargie HJ, Selwyn AP. Objective assessment of treatment in severe angina.Br Med J 1979; 289:1540.

    Article  Google Scholar 

  32. Dargie HJ, Lynch PG, Krikler DM, et al. Nifedipine and propranolol: A beneficial drug interaction.Am J Med 1981; 71:676–682.

    Article  PubMed  CAS  Google Scholar 

  33. Cocco G, Strozzi C, Chu D, et al. Therapeutic effects of pindolol and nifedipine in patients with stable angina pectoris and asymptomatic resting ischemia.Eur J Cardiol 1979;10:59–69.

    PubMed  CAS  Google Scholar 

  34. Crake T, Mulcahy D, Wright C, Fox K. Labetolol in the treatment of stable exertional angina pectoris: A comparison with nifedipine.Eur Soc Cardiol 1988;1200–1204.

  35. Bala Subramanian V, Bowles MJ, Khurmi NS, et al. Rationale for the choice of calcium antagonists in chronic stable angina: An objective double-blind, placebo-controlled comparison of nifedipine and verapamil.Am J Cardiol 1982;50:1173–1179.

    Article  PubMed  Google Scholar 

  36. Mulcahy D, Cunningham D, Crean P, et al. Circadian variation of total ischaemic burden and its alteration with antianginal agents.Lancet 1988;2:755–759.

    Article  PubMed  CAS  Google Scholar 

  37. Cohn PF, Vetrovec GW, Nesto R. Gerber FR and the Total Ischemia-Awareness Program Investigators. The Nifedipine-Total Ischemia-Awareness Program: A national survey of painful and painless myocardial ischemia including results of anti-ischemic therapy.Am J Cardiol 1989;63:534–539.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cardiology Section, New England Deaconess Hospital, 185 Pilgrim Road, 02215, Boston, MA, USA

    Richard W. Nesto MD

Authors
  1. Richard W. Nesto MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nesto, R.W. Rationale for treatment of silent myocardial ischemia: Focus on nifedipine. Cardiovasc Drug Ther 4 (Suppl 5), 929–934 (1990). https://doi.org/10.1007/BF02018295

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02018295

Key Words

Search

Navigation